@article{kristensen_sick_2012,
	title = {Sick leave in patients with ankylosing spondylitis before and after anti-{TNF} therapy: a population-based cohort study.},
	volume = {51},
	issn = {1462-0332 1462-0324},
	doi = {10.1093/rheumatology/ker169},
	abstract = {{OBJECTIVE}: To study levels of sick leave and disability pension before and after},
	pages = {243--249},
	number = {2},
	journaltitle = {Rheumatology (Oxford, England)},
	shortjournal = {Rheumatology (Oxford)},
	author = {Kristensen, Lars E. and Petersson, Ingemar F. and Geborek, Pierre and Joud, Anna and Saxne, Tore and Jacobsson, Lennart T. H. and Englund, Martin},
	date = {2012-02},
	pmid = {21565900},
	keywords = {Adolescent, Adult, Antibodies, Monoclonal/*administration \& dosage, Antibodies, Monoclonal, Humanized/*administration \& dosage, Antirheumatic Agents/*administration \& dosage, Case-Control Studies, Cohort Studies, Disability Evaluation, Disabled Persons/*statistics \& numerical data, Etanercept, Female, Humans, Immunoglobulin G/*administration \& dosage, Infliximab, Male, Middle Aged, Pain Measurement, Prospective Studies, Receptors, Tumor Necrosis Factor/*administration \& dosage, Registries, Sick Leave/*statistics \& numerical data, Spondylitis, Ankylosing/*drug therapy/physiopathology, Sweden, Treatment Outcome, Tumor Necrosis Factor-alpha/*antagonists \& inhibitors, Young Adult}
}

{"_id":"vNBbMjCXTzrbZnDTH","bibbaseid":"kristensen-petersson-geborek-joud-saxne-jacobsson-englund-sickleaveinpatientswithankylosingspondylitisbeforeandafterantitnftherapyapopulationbasedcohortstudy","downloads":0,"creationDate":"2017-03-31T11:02:36.909Z","title":"Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study.","author_short":["Kristensen, L. E.","Petersson, I. F.","Geborek, P.","Joud, A.","Saxne, T.","Jacobsson, L. T. H.","Englund, M."],"year":null,"bibtype":"article","biburl":"http://clinicalepidemiology.se/ClinEpi_LU.bib","bibdata":{"bibtype":"article","type":"article","title":"Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study.","volume":"51","issn":"1462-0332 1462-0324","doi":"10.1093/rheumatology/ker169","abstract":"OBJECTIVE: To study levels of sick leave and disability pension before and after","pages":"243--249","number":"2","journaltitle":"Rheumatology (Oxford, England)","shortjournal":"Rheumatology (Oxford)","author":[{"propositions":[],"lastnames":["Kristensen"],"firstnames":["Lars","E."],"suffixes":[]},{"propositions":[],"lastnames":["Petersson"],"firstnames":["Ingemar","F."],"suffixes":[]},{"propositions":[],"lastnames":["Geborek"],"firstnames":["Pierre"],"suffixes":[]},{"propositions":[],"lastnames":["Joud"],"firstnames":["Anna"],"suffixes":[]},{"propositions":[],"lastnames":["Saxne"],"firstnames":["Tore"],"suffixes":[]},{"propositions":[],"lastnames":["Jacobsson"],"firstnames":["Lennart","T.","H."],"suffixes":[]},{"propositions":[],"lastnames":["Englund"],"firstnames":["Martin"],"suffixes":[]}],"date":"2012-02","pmid":"21565900","keywords":"Adolescent, Adult, Antibodies, Monoclonal/*administration & dosage, Antibodies, Monoclonal, Humanized/*administration & dosage, Antirheumatic Agents/*administration & dosage, Case-Control Studies, Cohort Studies, Disability Evaluation, Disabled Persons/*statistics & numerical data, Etanercept, Female, Humans, Immunoglobulin G/*administration & dosage, Infliximab, Male, Middle Aged, Pain Measurement, Prospective Studies, Receptors, Tumor Necrosis Factor/*administration & dosage, Registries, Sick Leave/*statistics & numerical data, Spondylitis, Ankylosing/*drug therapy/physiopathology, Sweden, Treatment Outcome, Tumor Necrosis Factor-alpha/*antagonists & inhibitors, Young Adult","bibtex":"@article{kristensen_sick_2012,\n\ttitle = {Sick leave in patients with ankylosing spondylitis before and after anti-{TNF} therapy: a population-based cohort study.},\n\tvolume = {51},\n\tissn = {1462-0332 1462-0324},\n\tdoi = {10.1093/rheumatology/ker169},\n\tabstract = {{OBJECTIVE}: To study levels of sick leave and disability pension before and after},\n\tpages = {243--249},\n\tnumber = {2},\n\tjournaltitle = {Rheumatology (Oxford, England)},\n\tshortjournal = {Rheumatology (Oxford)},\n\tauthor = {Kristensen, Lars E. and Petersson, Ingemar F. and Geborek, Pierre and Joud, Anna and Saxne, Tore and Jacobsson, Lennart T. H. and Englund, Martin},\n\tdate = {2012-02},\n\tpmid = {21565900},\n\tkeywords = {Adolescent, Adult, Antibodies, Monoclonal/*administration \\& dosage, Antibodies, Monoclonal, Humanized/*administration \\& dosage, Antirheumatic Agents/*administration \\& dosage, Case-Control Studies, Cohort Studies, Disability Evaluation, Disabled Persons/*statistics \\& numerical data, Etanercept, Female, Humans, Immunoglobulin G/*administration \\& dosage, Infliximab, Male, Middle Aged, Pain Measurement, Prospective Studies, Receptors, Tumor Necrosis Factor/*administration \\& dosage, Registries, Sick Leave/*statistics \\& numerical data, Spondylitis, Ankylosing/*drug therapy/physiopathology, Sweden, Treatment Outcome, Tumor Necrosis Factor-alpha/*antagonists \\& inhibitors, Young Adult}\n}\n\n","author_short":["Kristensen, L. E.","Petersson, I. F.","Geborek, P.","Joud, A.","Saxne, T.","Jacobsson, L. T. H.","Englund, M."],"key":"kristensen_sick_2012","id":"kristensen_sick_2012","bibbaseid":"kristensen-petersson-geborek-joud-saxne-jacobsson-englund-sickleaveinpatientswithankylosingspondylitisbeforeandafterantitnftherapyapopulationbasedcohortstudy","role":"author","urls":{},"keyword":["Adolescent","Adult","Antibodies","Monoclonal/*administration & dosage","Antibodies","Monoclonal","Humanized/*administration & dosage","Antirheumatic Agents/*administration & dosage","Case-Control Studies","Cohort Studies","Disability Evaluation","Disabled Persons/*statistics & numerical data","Etanercept","Female","Humans","Immunoglobulin G/*administration & dosage","Infliximab","Male","Middle Aged","Pain Measurement","Prospective Studies","Receptors","Tumor Necrosis Factor/*administration & dosage","Registries","Sick Leave/*statistics & numerical data","Spondylitis","Ankylosing/*drug therapy/physiopathology","Sweden","Treatment Outcome","Tumor Necrosis Factor-alpha/*antagonists & inhibitors","Young Adult"],"downloads":0},"search_terms":["sick","leave","patients","ankylosing","spondylitis","before","anti","tnf","therapy","population","based","cohort","study","kristensen","petersson","geborek","joud","saxne","jacobsson","englund"],"keywords":["adolescent","adult","antibodies","monoclonal/*administration & dosage","antibodies","monoclonal","humanized/*administration & dosage","antirheumatic agents/*administration & dosage","case-control studies","cohort studies","disability evaluation","disabled persons/*statistics & numerical data","etanercept","female","humans","immunoglobulin g/*administration & dosage","infliximab","male","middle aged","pain measurement","prospective studies","receptors","tumor necrosis factor/*administration & dosage","registries","sick leave/*statistics & numerical data","spondylitis","ankylosing/*drug therapy/physiopathology","sweden","treatment outcome","tumor necrosis factor-alpha/*antagonists & inhibitors","young adult"],"authorIDs":["58de1314e37c0a4446000026"],"dataSources":["824aokLfuuJkJwfhw"]}